Excelimmune's Series B - II Round

Excelimmune raised a round of funding on May 31, 2011.

Excelimmune is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. This next generation technolog…

Articles about Excelimmune's Series B - II Round: